Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
50.39
+0.84 (1.70%)
Jan 5, 2026, 3:04 PM CST
60.17% (1Y)
| Market Cap | 55.24B |
| Revenue (ttm) | 4.25B |
| Net Income (ttm) | 672.56M |
| Shares Out | 1.11B |
| EPS (ttm) | 0.60 |
| PE Ratio | 82.55 |
| Forward PE | 82.31 |
| Dividend | 0.50 (1.01%) |
| Ex-Dividend Date | May 14, 2025 |
| Volume | 11,367,763 |
| Average Volume | 5,297,713 |
| Open | 49.69 |
| Previous Close | 49.55 |
| Day's Range | 48.84 - 51.73 |
| 52-Week Range | 27.66 - 65.63 |
| Beta | 0.61 |
| RSI | 27.18 |
| Earnings Date | Mar 24, 2026 |